Taurine trial targets long COVID brain fog

NCT ID NCT06721949

Recruiting now Symptom relief Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether taking taurine supplements can reduce brain fog, memory problems, and fatigue in people with Long COVID. About 300 adults who had COVID-19 at least 3 months ago will take taurine or a placebo for 3 months. Researchers will measure changes in fatigue and thinking speed using simple tests and surveys.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LONG COVID

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

BC Women's Hospital
NOT_YET_RECRUITING

Vancouver, British Columbia, V6H 3N1, Canada

Contact Email: •••••@•••••

Contact Email: •••••@•••••
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke
NOT_YET_RECRUITING

Sherbrooke, Quebec, Canada

Contact Email: •••••@•••••

Contact Email: •••••@•••••
Institut de recherches cliniques de Montréal
RECRUITING

Montreal, Quebec, Canada

Contact Email: •••••@•••••

Contact Email: •••••@•••••
University Health Network
RECRUITING

Toronto, Ontario, Canada

Contact Email: •••••@•••••

Contact Email: •••••@•••••
University of Alberta Hospital, Kaye Edmonton Clinic
RECRUITING

Edmonton, Alberta, T6G 2B7, Canada

Contact Email: •••••@•••••

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.